4BASEBIO PLC EO 1
Research 4BASEBIO PLC EO 1 (88Q) on Bullrun: market cap EUR 55.44M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker88Q
- ExchangeF
- CountryUnited Kingdom
- SectorHealthcare
- IndustryBiotechnology
- CurrencyEUR
- Market capEUR 55.44M
- Financial periodFY2025
- RevenueGBP 1.69M
- Revenue growth81.5%
- Net income-GBP 16.91M
- Free cash flow-GBP 17.23M
- Gross margin57.5%
Valuation Snapshot
latest market cap is EUR 55.44M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | GBP 1.69M | -GBP 16.91M | -GBP 17.23M | 57.5% | -1.09 | GBP 17.80M | GBP 16.72M | GBP 10.11M |
| FY2024 | GBP 933.00K | -GBP 12.33M | -GBP 12.32M | 67.5% | -0.94 | GBP 34.60M | GBP 15.22M | GBP 26.38M |
| FY2023 | GBP 506.00K | -GBP 7.67M | -GBP 7.67M | 67.2% | -0.62 | GBP 3.07M | GBP 10.46M | -GBP 492.00K |
| FY2022 | GBP 268.00K | -GBP 5.15M | -GBP 6.65M | 89.2% | -0.42 | GBP 4.35M | GBP 3.35M | GBP 7.12M |
| FY2021 | GBP 338.00K | -GBP 3.24M | -GBP 4.25M | 79.6% | -0.26 | GBP 9.59M | GBP 1.76M | GBP 11.70M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-27 | EUR 55.44M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 EUR.
About 4BASEBIO PLC EO 1
4basebio PLC, together with its subsidiaries, engages in the research, development, manufacturing, and sale of synthetic DNA and RNA products in Europe, the United States, and internationally. It offers hpDNA, a double stranded linear DNA for viral and non-viral vector applications; opDNA, a partially opened, linear, double stranded DNA for in vitro transcription processes that produce mRNA for use in vaccines and therapeutics; oeDNA, a linear, double stranded DNA for genome editing;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is 4BASEBIO PLC EO 1's market cap?
4BASEBIO PLC EO 1's market capitalization is EUR 55.44M.
What does 4BASEBIO PLC EO 1 do?
4basebio PLC, together with its subsidiaries, engages in the research, development, manufacturing, and sale of synthetic DNA and RNA products in Europe, the United States, and internationally.